Bio-Rad Lab-A
BIO
USD
STOCK MARKET:
NYX
Open
 
...
Price in deferred time of 15 minutes
Last quote
03/28/2024 - 13:29:35
Bid
03/28/2024 - 13:28:52
Bid
Volume
Ask
03/28/2024 - 13:28:52
Ask
Volume
347.27
-2.29 ( -0.66% )
344.97
100
348.54
100
More information
Analysis by TheScreener
26.03.2024
Evaluation Slightly negative  
Interest Very weak  
Sensibility High  
Analysis date: 26.03.2024
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 16.02.2024.
Interest
  Very weak
Very weak interest since 19.03.2024.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 16.02.2024 at a price of 340.52.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
  Positive
 
The forty day Medium Term Technical Trend is positive since 22.12.2023. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 326.572.
4wk Rel Perf
  -1.95%
 
The four week relative underperformance versus SP500 is 1.95%.
Sensibility
  High
The stock has been on the high-sensitivity level since 16.02.2024.
Bear Market Factor
  High
On average, the stock has a tendency to amplify the drops in the index by 0.77%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.93%.
Mkt Cap in $bn
  9.73
With a market capitalization >$8bn, BIO-RAD LABORATORIES is considered a large-cap stock.
G/PE Ratio
  0.58
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
  30.35
The estimated PE is for the year 2025.
LT Growth
  17.56%
The annualized growth estimate is for the current year to 2025.
Avg. Nb analysts
  5
Over the last seven weeks, an average of 5 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  118
For 1% of index variation, the stock varies on average by 1.18%.
Correlation
  0.46
46.47% of stock movements are explained by index variations.
Value at Risk
  106.01
The value at risk is estimated at USD 106.01. The risk is therefore 31.13%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  23.10.2018